COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study

BACKGROUND: Ipratropium bromide/albuterol Respimat inhaler (CVT-R) was developed as an environmentally friendly alternative to ipratropium bromide/albuterol metered-dose inhaler (CVT-MDI), which uses a chlorofluorocarbon propellant. OBJECTIVE: The objective of this study was to evaluate patient sati...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ferguson, Gary T, Ghafouri, Mo, Dai, Luyan, Dunn, Leonard J
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2013
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607534/
https://ncbi.nlm.nih.gov/pubmed/23658479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S38577
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires